Figure 2.
ARQ-197 inhibits the survival of HCC cells in a dose-dependent manner.
Notes: HCC cells MHCC97-H (A), LM-3 (B), and HepG2 (C), which were treated with indicated concentrations of ARQ-197, were analyzed by MTT experiments. Inhibition rate of ARQ-197 on HCC cells was calculated at OD 490 nm.
Abbreviation: HCC, hepatocellular carcinoma.